We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Sandbox Reserved 820
From Proteopedia
(Difference between revisions)
(New page: <!-- PLEASE DO NOT DELETE THIS TEMPLATE --> {{Sandbox_Reserved_ESBS}} <!-- PLEASE ADD YOUR CONTENT BELOW HERE -->) |
|||
| Line 2: | Line 2: | ||
{{Sandbox_Reserved_ESBS}} | {{Sandbox_Reserved_ESBS}} | ||
<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | <!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
| + | ''' | ||
| + | == Introduction == | ||
| + | ''' | ||
| + | Calsequestrin-2 (or CASQ2) is the soluble CA2+ binding protein in the sarcoplasmic reticulum lumen of the cardiac muscle cells. CASQ2 could be either in a monomeric, homodimeric, or homooligomeric chain form depending on its bounds with Ca2+. Mutations of CASQ2 are involved in cardiac diseases such as Catecholaminergic Polymorphic Ventricular Tachycardia. | ||
| + | |||
| + | <scene name='56/568018/General_structure/2'>TextToBeDisplayed</scene> | ||
Revision as of 21:20, 28 December 2013
| This Sandbox is Reserved from 06/12/2018, through 30/06/2019 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1480 through Sandbox Reserved 1543. |
To get started:
More help: Help:Editing |
Introduction
Calsequestrin-2 (or CASQ2) is the soluble CA2+ binding protein in the sarcoplasmic reticulum lumen of the cardiac muscle cells. CASQ2 could be either in a monomeric, homodimeric, or homooligomeric chain form depending on its bounds with Ca2+. Mutations of CASQ2 are involved in cardiac diseases such as Catecholaminergic Polymorphic Ventricular Tachycardia.
